| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.8 |